extremity trauma is a frequent reason for emergency room visits. There is a...
Status
Completed
Location
Takieddine ADDALA
Start Date
2018-02-01
Trial ID
NCT04832490
The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA.
PHASE2
The aim of the study to evaluate the performance of new \[18F\]-AlF-FAPI-74...
Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients
N/A
The purpose of the study is to determine the Pharmacokinetics of Low Molecu...
Status
Completed
Location
Shaare Zedek Medicla Center
Start Date
2009-02
Trial ID
NCT00716898
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
PHASE1
This phase I trial studies the safety and side effects of a new positron em...
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
PHASE3
This phase III trial is studying vincristine, dactinomycin, and doxorubicin...